The FTC's Ongoing Opposition To Reverse Payments
The "Drug Price Competition and Patent Term Restoration Act of 1984," more often called "Hatch-Waxman," regulates the generic drug industry in the United States. Hatch-Waxman reflects an attempt by Congress to...To view the full article, register now.
Already a subscriber? Click here to view full article